Media resources
Explore the latest CEPI resources designed to help journalists and partners tell the CEPI story and stay up-to-date on the latest pandemic preparedness news.
Media enquiries
If you're a journalist and would like to find out more about our work or arrange an interview with one of our experts, you can reach us via email and we’ll get back to you as soon as possible. Alternatively, please call our press line for any out of hours enquiries.
Email: [email protected]
Phone: +44 7387 055214
CEPI backgrounder
Read our CEPI backgrounder to find out more about CEPI’s history, vision, and progress to date, and our work on the 100 Days Mission to better prepare for future pandemics.
CEPI’s pandemic plan
Learn more about CEPI 2.0 to help prepare, transform and connect the world so that it can respond to the next Disease X threat with a new vaccine in just three months.
GPPS 2024: Outcomes Report
This report distils the discussions, reflections, and recommendations that emerged from the diverse field of over 80 expert speakers that took part in the Global Pandemic Preparedness Summit 2024, held in Rio de Janeiro, Brazil in July 2024. The report is available in English and Portuguese.
COVID-19 Impact assessment media resources
Access high-resolution graphs and graphics in various formats, designed for use in approved media and communications materials.
CEPI logos
Access hi-res copies of the CEPI logo in various design formats for use in online and print materials.
Explainer blogs
.webp){kind=logo}
The Pandemic Agreement - What it is, and what it is not
Viral vector vaccines – What they are, and what they are not
mRNA vaccines – What they are, and what they are not
Protein subunit vaccines – What they are, and what they are not
Marburg – What it is, and what it is not
Mpox – What it is, and what it is not
DISEASE X - What it is, and what it is not
What are monoclonal antibodies, and what role could they play in ending a potential pandemic?
Progress and results
CEPI is catalysing the development of vaccines and biologics against epidemic and pandemic threats, working to make them accessible to everyone who needs them and driving progress on the 100 Days Mission. Learn more about our progress and results.
Impact in focus
CEPI supports more than 150 active R&D and manufacturing projects in over 50 countries around the world, building critical capabilities for the 100 Days Mission. Find out how CEPI is advancing scientific innovations that could transform vaccine development and pandemic preparedness.
